Drugs / BB4 antibody-Iodine 131
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01296204 | — | plasma cell myeloma | Centre René Gauducheau | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BB4 antibody-Iodine 131 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01296204 ↗ |